You are here

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Phoenix, Arizona, 85004 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of probable Alzheimer Disease according to the National Institute of
Neurological and Communicative Disorders and Stroke-Alzheimer's Diseases and Related
Disorders Association (NINCDS-ADRDA) criteria.

- Mini-Mental State Examination (MMSE) score of 12 to 24 at screening

- Rosen Modified Hachinski Ischemic score

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Relevant neurologic disease other than Alzheimer Disease that may affect cognition or
ability to complete the study.

- Current major depressive disorder or other current major psychiatric disorder.

- History of clinically evident stroke or clinically important carotid or
vertebrobasilar stenosis or plaque.

- Use of prescription or nonprescription medications for cognitive enhancement
(including memantine, ginkgo biloba, huperzine A, and cholinesterase inhibitors)
within 3 months before the baseline visit.

NCT00895895
Pfizer
Terminated
Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Alzheimer Disease, Caregivers
NCT00467766
All Genders
21+
Years
Multiple Sites
Alzheimer Disease
NCT00479219
All Genders
18+
Years
Glendale, California
Alzheimer Disease, Healthy
NCT00718731
All Genders
18+
Years
New York, New York
Alzheimer Disease, Healthy
NCT00499642
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now